WASHINGTON, D.C. — Patients For Affordable Drugs NOW is launching a national advertising campaign to push for passage of the CREATES Act, a bipartisan bill that would lower drug prices and save taxpayers billions. In his State of the Union address, President Trump promised to “make fixing the injustice of high drug prices one of our top priorities for the year.”
The six-figure ad buy will focus on Senators and House Members in Arizona, Florida, Kentucky, Pennsylvania, Wisconsin, West Virginia, and DC. The campaign will include buys on social media platforms like Facebook and Twitter, news outlets like the Wall Street Journal, Milwaukee Journal Sentinel, and Arizona Republic, and geotargeted buys to make voters aware of the CREATES Act.
The CREATES Act (S. 974 and H.R. 2212) would stop big drug companies from blocking competition by refusing to allow their brand name drugs to be used in testing needed to get approval for generic competitors. If passed, people would get access to lower priced generic drugs faster.
“We hear from patients every day who are being forced to choose between buying groceries and taking lifesaving drugs,” said David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs NOW. “Americans are hurt, angry, and demand action from Washington. The CREATES Act is a bipartisan bill to halt drug company abuses that keep prices high. It should pass immediately.”
In addition to the six-figure ad buy, which runs until February 7, Patients For Affordable Drugs NOW will:
- Fly patients to meet elected officials in Washington to discuss the need for lower drug prices.
- Organize phone calls and letters to members of the House and Senate featuring stories of patients in their districts and urging support for the bill.
- Launch an online advocacy tool that allows constituents to directly contact their elected representatives and urge support for the bill.
- Engage patients and their families on social media to share their stories and demand action.
According to the Congressional Budget Office, the CREATES Act would save taxpayers $3.3 billion over the next decade. The pharmaceutical lobby spent $25 million last year and continues to oppose the CREATES Act despite calls from FDA Commissioner Scott Gottlieb, Freedom Works, and the Heritage Foundation to pass the bill.
Patients For Affordable Drugs NOW aims to act as a counterbalance to drug corporation influence and will conduct on-the-ground advocacy in support of candidates and policies to curb drug prices. It does not accept funding from any organizations that profit from the development or distribution of prescription drugs.